212 related articles for article (PubMed ID: 25081749)
1. Aberrant expression of annexin A10 is closely related to gastric phenotype in serrated pathway to colorectal carcinoma.
Tsai JH; Lin YL; Cheng YC; Chen CC; Lin LI; Tseng LH; Cheng ML; Liau JY; Jeng YM
Mod Pathol; 2015 Feb; 28(2):268-78. PubMed ID: 25081749
[TBL] [Abstract][Full Text] [Related]
2. Annexin A10 expression correlates with serrated pathway features in colorectal carcinoma with microsatellite instability.
Kim JH; Rhee YY; Kim KJ; Cho NY; Lee HS; Kang GH
APMIS; 2014 Dec; 122(12):1187-95. PubMed ID: 24909058
[TBL] [Abstract][Full Text] [Related]
3. Expression of MUC2, MUC5AC, MUC5B, and MUC6 mucins in colorectal cancers and their association with the CpG island methylator phenotype.
Walsh MD; Clendenning M; Williamson E; Pearson SA; Walters RJ; Nagler B; Packenas D; Win AK; Hopper JL; Jenkins MA; Haydon AM; Rosty C; English DR; Giles GG; McGuckin MA; Young JP; Buchanan DD
Mod Pathol; 2013 Dec; 26(12):1642-56. PubMed ID: 23807779
[TBL] [Abstract][Full Text] [Related]
4. Annexin A10 expression in colorectal cancers with emphasis on the serrated neoplasia pathway.
Bae JM; Kim JH; Rhee YY; Cho NY; Kim TY; Kang GH
World J Gastroenterol; 2015 Sep; 21(33):9749-57. PubMed ID: 26361422
[TBL] [Abstract][Full Text] [Related]
5. Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points.
O'Brien MJ; Yang S; Mack C; Xu H; Huang CS; Mulcahy E; Amorosino M; Farraye FA
Am J Surg Pathol; 2006 Dec; 30(12):1491-501. PubMed ID: 17122504
[TBL] [Abstract][Full Text] [Related]
6. Annexin A10 is a marker for the serrated pathway of colorectal carcinoma.
Sajanti SA; Väyrynen JP; Sirniö P; Klintrup K; Mäkelä J; Tuomisto A; Mäkinen MJ
Virchows Arch; 2015 Jan; 466(1):5-12. PubMed ID: 25395067
[TBL] [Abstract][Full Text] [Related]
7. Molecular characterization of sessile serrated adenoma/polyps with dysplasia/carcinoma based on immunohistochemistry, next-generation sequencing, and microsatellite instability testing: a case series study.
Murakami T; Akazawa Y; Yatagai N; Hiromoto T; Sasahara N; Saito T; Sakamoto N; Nagahara A; Yao T
Diagn Pathol; 2018 Nov; 13(1):88. PubMed ID: 30458818
[TBL] [Abstract][Full Text] [Related]
8. Gastric-type expression signature in serrated pathway-associated colorectal tumors.
Kim JH; Kim KJ; Rhee YY; Bae JM; Cho NY; Lee HS; Kang GH
Hum Pathol; 2015 May; 46(5):643-56. PubMed ID: 25704805
[TBL] [Abstract][Full Text] [Related]
9. Traditional serrated adenoma has two pathways of neoplastic progression that are distinct from the sessile serrated pathway of colorectal carcinogenesis.
Tsai JH; Liau JY; Lin YL; Lin LI; Cheng YC; Cheng ML; Jeng YM
Mod Pathol; 2014 Oct; 27(10):1375-85. PubMed ID: 24603588
[TBL] [Abstract][Full Text] [Related]
10. Serrated pathway in colorectal carcinogenesis.
Yamane L; Scapulatempo-Neto C; Reis RM; Guimarães DP
World J Gastroenterol; 2014 Mar; 20(10):2634-40. PubMed ID: 24627599
[TBL] [Abstract][Full Text] [Related]
11. Subtypes of the Type II Pit Pattern Reflect Distinct Molecular Subclasses in the Serrated Neoplastic Pathway.
Aoki H; Yamamoto E; Yamano HO; Sugai T; Kimura T; Tanaka Y; Matsushita HO; Yoshikawa K; Takagi R; Harada E; Nakaoka M; Yoshida Y; Harada T; Sudo G; Eizuka M; Yorozu A; Kitajima H; Niinuma T; Kai M; Nojima M; Suzuki H; Nakase H
Dig Dis Sci; 2018 Jul; 63(7):1920-1928. PubMed ID: 29546645
[TBL] [Abstract][Full Text] [Related]
12. Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway.
Kim JH; Bae JM; Cho NY; Kang GH
Oncotarget; 2016 Mar; 7(12):14095-111. PubMed ID: 26883113
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemistry for annexin A10 can distinguish sporadic from Lynch syndrome-associated microsatellite-unstable colorectal carcinoma.
Pai RK; Shadrach BL; Carver P; Heald B; Moline J; Church J; Kalady MF; Burke CA; Plesec TP; Lai KK; Gonzalo DH; Pai RK
Am J Surg Pathol; 2014 Apr; 38(4):518-25. PubMed ID: 24625416
[TBL] [Abstract][Full Text] [Related]
14. [Serrated pathway of colorectal carcinogenesis].
Baretton GB
Pathologe; 2010 Feb; 31(1):9-15. PubMed ID: 19921196
[TBL] [Abstract][Full Text] [Related]
15. Morphologic and molecular characterization of traditional serrated adenomas of the distal colon and rectum.
Wiland HO; Shadrach B; Allende D; Carver P; Goldblum JR; Liu X; Patil DT; Rybicki LA; Pai RK
Am J Surg Pathol; 2014 Sep; 38(9):1290-7. PubMed ID: 25127095
[TBL] [Abstract][Full Text] [Related]
16. The serrated neoplasia pathway of colorectal tumors: Identification of MUC5AC hypomethylation as an early marker of polyps with malignant potential.
Renaud F; Mariette C; Vincent A; Wacrenier A; Maunoury V; Leclerc J; Coppin L; Crépin M; Van Seuningen I; Leteurtre E; Buisine MP
Int J Cancer; 2016 Mar; 138(6):1472-81. PubMed ID: 26476272
[TBL] [Abstract][Full Text] [Related]
17. Possible role of Cdx2 in the serrated pathway of colorectal cancer characterized by BRAF mutation, high-level CpG Island methylator phenotype and mismatch repair-deficiency.
Dawson H; Galván JA; Helbling M; Muller DE; Karamitopoulou E; Koelzer VH; Economou M; Hammer C; Lugli A; Zlobec I
Int J Cancer; 2014 May; 134(10):2342-51. PubMed ID: 24166180
[TBL] [Abstract][Full Text] [Related]
18. Molecular Subtypes of Colorectal Cancer and Their Clinicopathologic Features, With an Emphasis on the Serrated Neoplasia Pathway.
Bae JM; Kim JH; Kang GH
Arch Pathol Lab Med; 2016 May; 140(5):406-12. PubMed ID: 27128298
[TBL] [Abstract][Full Text] [Related]
19. CpG Island Methylator Phenotype-High Colorectal Cancers and Their Prognostic Implications and Relationships with the Serrated Neoplasia Pathway.
Rhee YY; Kim KJ; Kang GH
Gut Liver; 2017 Jan; 11(1):38-46. PubMed ID: 27885175
[TBL] [Abstract][Full Text] [Related]
20. Biomarkers for the identification of precursor polyps of colorectal serrated adenocarcinomas.
García-Solano J; García-Solano ME; Torres-Moreno D; Carbonell P; Trujillo-Santos J; Pérez-Guillermo M; Conesa-Zamora P
Cell Oncol (Dordr); 2016 Jun; 39(3):243-52. PubMed ID: 26832730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
